Login to Your Account



Flomax Generics Due Next Year

BPH Market War Simmering; AEterna Slips, More to Come

By Randy Osborne


Monday, August 24, 2009
Prostate cancer, deadly though sometimes slow-moving, gets far more press, but benign prostatic hyperplasia - enlargement (usually associated with age) of the male gland that contributes alkalinity to sperm fluid, letting the reproductive tadpoles swim longer - represented a $3.7 billion market last year. And plenty of players are on the case.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription